December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on ...
News | Nuclear Imaging
Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be detected ...
December 12, 2016 
November 2, 2016 — By the time unambiguous signs of memory loss and cognitive decline appear in people with Alzheimer’s ...
November 02, 2016 Sponsored Content
Videos | Contrast Media
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
February 27, 2023 
October 28, 2016 — The National Academies of Sciences, Engineering, and Medicine (NAS) have released a report on the ...
October 28, 2016 
News | Prostate Cancer
October 25, 2016 — Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 ...
October 25, 2016 
October 17, 2016 — Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 ...
October 17, 2016 Sponsored Content
Blog | Contrast Media Injectors
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
April 29, 2021 
Feature | Neuro Imaging
September 9, 2016 — The Alzheimer’s Disease Neuroimaging Initiative (ADNI) recently launched into its next phase, ADNI3 ...
September 09, 2016 
September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA) ...
September 07, 2016 September 6, 2016 — Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with ...
September 06, 2016 
News | PET Imaging
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...
September 01, 2016 
July 12, 2016 — Lantheus Holdings Inc., the parent company of Lantheus Medical Imaging Inc. (LMI), announced the first ...
July 12, 2016 
July 7, 2016 — Cell>Point announced in mid-June it has entered into an exclusive license agreement for China, Hong Kong ...
July 07, 2016 
July 6, 2016 — Navidea Biopharmaceuticals Inc. announced results from three investigator-initiated studies of the ...
July 06, 2016 
News | Oncology Diagnostics
June 23, 2016 — Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and ...
June 23, 2016 
News | PET Imaging
June 23, 2016 — The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years ...
June 23, 2016 
News | Nuclear Imaging
June 23, 2016 — Aggressive neuroendocrine cancer is something of a dark horse — a rare, elusive and persevering force ...
June 23, 2016 
News | PET Imaging
June 22, 2016 — Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to ...
June 22, 2016 
June 20, 2016 — An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of ...
June 20, 2016 
Feature | PET Imaging
June 20, 2016 — Positron emission tomography (PET) with three different radiotracers can now measure amyloid plaques ...
June 20, 2016 News | Prostate Cancer
June 17, 2016 — Decatur Memorial Hospital, Decatur, Ill., is now offering C-11 choline positron emission tomography (PET ...
June 17, 2016 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now